These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 4082237)

  • 41. Deviations from Michaelis-Menten kinetics. The possibility of complicated curves for simple kinetic schemes and the computer fitting of experimental data for acetylcholinesterase, acid phosphatase, adenosine deaminase, arylsulphatase, benzylamine oxidase, chymotrypsin, fumarase, galactose dehydrogenase, beta-galactosidase, lactate dehydrogenase, peroxidase and xanthine oxidase.
    Bardsley WG; Leff P; Kavanagh J; Waight RD
    Biochem J; 1980 Jun; 187(3):739-65. PubMed ID: 6821369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel method of estimating volume of distribution of a drug obeying Michaelis-Menten elimination kinetics.
    Lin YJ; Weidler DJ; Garg DC; Wagner JG
    J Pharmacokinet Biopharm; 1978 Jun; 6(3):197-207. PubMed ID: 671226
    [No Abstract]   [Full Text] [Related]  

  • 43. Nonlinear pharmacokinetics: clinical Implications.
    Ludden TM
    Clin Pharmacokinet; 1991 Jun; 20(6):429-46. PubMed ID: 2044328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validity of the Michaelis-Menten equation--steady-state or reactant stationary assumption: that is the question.
    Schnell S
    FEBS J; 2014 Jan; 281(2):464-72. PubMed ID: 24245583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Michaelis-Menten absorption kinetics in drugs: - examples and implications.
    Wood JH; Thakker KM
    Eur J Clin Pharmacol; 1982; 23(2):183-8. PubMed ID: 7140809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Michaelis-Menten kinetics determine cyclosporine steady-state concentrations: a population analysis in kidney transplant patients.
    Grevel J; Post BK; Kahan BD
    Clin Pharmacol Ther; 1993 Jun; 53(6):651-60. PubMed ID: 8513657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationships between steady-state and single-dose plasma drug concentrations for pharmacokinetic systems with nonlinear elimination.
    Cheng HY; Jusko WJ
    Biopharm Drug Dispos; 1989; 10(5):513-28. PubMed ID: 2804255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Individualizing phenytoin dosage regimens using a programmable calculator.
    Ng PK
    Am J Hosp Pharm; 1980 Apr; 37(4):529-33. PubMed ID: 7377216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The reliability of Michaelis constants and maximum velocities estimated by using the integrated Michaelis-Menten equation.
    Atkins GL; Nimmo IA
    Biochem J; 1973 Dec; 135(4):779-84. PubMed ID: 4778274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Problems in the kinetic evaluation of capacity-limited processes by means of the analog computer MEDA 82 T.
    Franke G; Zschiesche M; Hüller H
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):410-2. PubMed ID: 700913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single dose and steady-state pharmacokinetics of adinazolam after oral administration to man.
    Wagner JG; Rogge MC; Natale RB; Albert KS; Szpunar GJ
    Biopharm Drug Dispos; 1987; 8(5):405-25. PubMed ID: 3663878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.
    Wu X; Nekka F; Li J
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):447-59. PubMed ID: 27405818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accumulation kinetics of propranolol in the rat: comparison of Michaelis-Menten-mediated clearance and clearance changes consistent with the "altered enzyme hypothesis".
    Weber C; Stoeckel K; Lalka D
    Pharm Res; 1994 Mar; 11(3):420-5. PubMed ID: 8008710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exact and approximate solutions for the decades-old Michaelis-Menten equation: Progress-curve analysis through integrated rate equations.
    Goličnik M
    Biochem Mol Biol Educ; 2011; 39(2):117-25. PubMed ID: 21445903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Half-time analysis of the integrated Michaelis equation. Simulation and use of the half-time plot and its direct linear variant in the analysis of some alpha-chymotrypsin, papain- and fumarase-catalysed reactions.
    Wharton CW; Szawelski RJ
    Biochem J; 1982 May; 203(2):351-60. PubMed ID: 7115291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computation of the explicit solution to the Michaelis-Menten equation.
    Beal SL
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):641-57. PubMed ID: 6689584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic approach to a dosage regimen for phenytoin based on one-point, steady-state plasma concentration.
    Nakashima E; Matsushita R; Kido H; Nakamura M; Asahi M; Ichimura F
    Ther Drug Monit; 1995 Feb; 17(1):12-8. PubMed ID: 7725371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.
    Ciraulo DA; Barnhill JG; Boxenbaum HG; Greenblatt DJ; Smith RB
    J Clin Pharmacol; 1986 Apr; 26(4):292-8. PubMed ID: 2871050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A guide to the Michaelis-Menten equation: steady state and beyond.
    Srinivasan B
    FEBS J; 2022 Oct; 289(20):6086-6098. PubMed ID: 34270860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetic parameter estimation by numerical algorithms and multiple linear regression: application to pharmacokinetics.
    Yeh KC; Kwan KC
    J Pharm Sci; 1979 Sep; 68(9):1120-4. PubMed ID: 501533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.